Top Markets
#1 Seeker Seeker +18.80%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.47%
#4 Arowana Arowana +5.88%
#5 MetaDAO MetaDAO +4.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +4.02%
#7 Mina Protocol Mina Protocol +3.88%
#8 Pons Pons +3.00%
#9 Solstice Solstice +2.88%
#10 Official Trump Official Trump +2.75%
Coin of the day
Seeker Seeker
設定
言語
日本
通貨
USD
テーマ
GH Research PLC GH Research PLC

GH Research PLC

GHRS
株式のランク #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
株価
$28.53
最終同期: 2026-08-27
時価総額
$1.96B
変化（1日）
-1.65%
変化（1年）
106.14%
国
IE
取引 GH Research PLC (GHRS)

カテゴリー

Healthcare
GH Research PLC（GHRS）のP/B比率
2026 時点のP/B比率 TTM: 0
GH Research PLC の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
GH Research PLC の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH